share_log

科濟藥業-B：建議授出發行股份及購回股份之一般授權、重選退任董事、續聘核數師、建議修訂現行組織章程大綱及細則及採納第八次經修訂及重述組織章程大綱及細則及股東週年大會通告

CARSGEN-B: PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, RE-ELECTION OF RETIRING DIRECTORS, RE-APPOINTMENT OF AUDITOR, PROPOSED AMENDMENTS TO THE CURRENT MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE EIGHTH AMENDED AND RESTATED ME

HKEX ·  Apr 18 05:05

Summary by Moomoo AI

科濟藥業控股有限公司（CARsgen Therapeutics Holdings Limited）將於2024年5月21日在中國上海市徐匯區舉行股東週年大會，會議將討論包括授出發行股份及購回股份之一般授權、重選退任董事、續聘核數師、建議修訂現行組織章程大綱及細則及採納第八次經修訂及重述組織章程大綱及細則等議題。此外，公司亦將省覽及採納截至2023年12月31日止年度之經審核綜合財務報表以及董事會及核數師報告。股東若無法出席大會，需根據代表委任表格指示填妥表格，並於2024年5月19日上午十時前交回公司香港證券登記分處。所有相關文件均已在公司及香港聯合交易所有限公司網站公佈。
科濟藥業控股有限公司（CARsgen Therapeutics Holdings Limited）將於2024年5月21日在中國上海市徐匯區舉行股東週年大會，會議將討論包括授出發行股份及購回股份之一般授權、重選退任董事、續聘核數師、建議修訂現行組織章程大綱及細則及採納第八次經修訂及重述組織章程大綱及細則等議題。此外，公司亦將省覽及採納截至2023年12月31日止年度之經審核綜合財務報表以及董事會及核數師報告。股東若無法出席大會，需根據代表委任表格指示填妥表格，並於2024年5月19日上午十時前交回公司香港證券登記分處。所有相關文件均已在公司及香港聯合交易所有限公司網站公佈。
CarsGen Therapeutics Holdings Limited will hold its Annual General Meeting on May 21, 2024 in Xuhui District, Shanghai, China. The meeting will include the granting of general mandates to issue shares and repurchase shares, re-election of retiring directors, renewal of auditors, proposed amendments to the current articles of association and Rules and issues such as the adoption of the eighth revised and restated articles of association and articles of association. In addition, the Company will review and adopt the audited consolidated financial statements for the year ended December 31, 2023, as well as the reports of the Board of Directors and Auditors. If shareholders are unable to attend the General Meeting, they are required to complete the form in accordance with the instructions on the Proxy Form and return it to the Company's Hong Kong Securities Registry by 10:00 a.m. on 19 May 2024. All relevant documents have been published on the Company and the United Stock Exchange Limited website.
CarsGen Therapeutics Holdings Limited will hold its Annual General Meeting on May 21, 2024 in Xuhui District, Shanghai, China. The meeting will include the granting of general mandates to issue shares and repurchase shares, re-election of retiring directors, renewal of auditors, proposed amendments to the current articles of association and Rules and issues such as the adoption of the eighth revised and restated articles of association and articles of association. In addition, the Company will review and adopt the audited consolidated financial statements for the year ended December 31, 2023, as well as the reports of the Board of Directors and Auditors. If shareholders are unable to attend the General Meeting, they are required to complete the form in accordance with the instructions on the Proxy Form and return it to the Company's Hong Kong Securities Registry by 10:00 a.m. on 19 May 2024. All relevant documents have been published on the Company and the United Stock Exchange Limited website.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated